Viral Vectors
Backbone of Innovation: How CDMO Vector Platforms Are Accelerating Gene Therapy Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-09Jul 21, 2025
Clinical Platforms
Why Clinical Trial Platforms Must Evolve from Tools to Strategy
Chris Driver
IQVIA
PAO-07-25-CL-03Jul 18, 2025
Formulation
Formulation and Analytics Platforms Transforming Drug Product Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-06Jul 16, 2025
Platforms
Built for Speed and Scale: How CDMO Cell Line Platforms Are Reshaping Biologic Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-05Jul 15, 2025
Formulation
Overcoming Challenges to High-Concentration Formulation Development
Heonchang Lim
Samsung Biologics
PAO-02-25-CL-19Mar 02, 2025
Developability
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Heonchang Lim
Samsung Biologics
PAO-09-24-CL-04Sep 04, 2024
Developability
Streamlining the Path to Approval with Developability and Pre-Formulation Platforms
Andrea Hawe
Coriolis Pharma
PAO-07-24-CL-11Aug 01, 2024
CRDO
Partnering with Scientific Excellence to De-Risk and Accelerate Drug Development
Silvia Steyrer-Gruber
Coriolis Pharma
PAO-07-24-CL-05Jul 16, 2024
Monoclonal Antibodies
Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings for Monoclonal Antibodies
Coriolis Pharma
PR-05-24-NI-02Jun 18, 2024